05/01/2026
We are proud to announce the appointment of Dr. Nathan Stolero, as the new CEO of Pharma Clinical! 🥳
Nathan takes on the role of CEO, as Pharma Clinical’s Founder and Dr. Dan Stolero continues his close and ongoing involvement with the company as Chairman and Medical Director, maintaining oversight of the company’s medical and professional excellence.
After 3.5 years as our Innovation Manager, Nathan brings a unique perspective. He holds a PhD in Communication, with expertise in health promotion and emergency management, and has held a range of senior professional and managerial roles across the health and public sectors. Nathan has served as a senior consultant on steering committees for government ministries, including the Ministry of Health, led large multidisciplinary research teams, and contributed to international projects in the fields of health, emergency management, and communication. Alongside his executive role, he continues to hold an academic appointment at Tel Aviv University.
As the son of our Dr. Dan Stolero, Nathan brings not only a fresh perspective but also a strong and indispensable personal connection to the company’s values and legacy. For over 35 years, Pharma Clinical has been driven by a commitment to clinical excellence, trust, and meaningful partnerships — values that continue to guide us into the future.
Now stepping into the role of CEO, Nathan will lead Pharma Clinical’s overall strategy and day-to-day management, building on the company’s strong foundations while continuing to develop new capabilities and areas of growth.
His motivation is clear: "This field is full of opportunities to make a real difference," Nathan shares. "Everything we do is a step toward developing new medicines and improving human health."
Nathan, from all of us at Pharma Clinical, good luck in this new chapter!
hashtag hashtag hashtag hashtag hashtag